Abound Wealth Management Vir Biotechnology, Inc. Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 16 shares of VIR stock, worth $156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$156
Previous $143,000
16.08%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VIR
# of Institutions
222Shares Held
86.4MCall Options Held
231KPut Options Held
132K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$163 Million1.37% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$161 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$126 Million0.0% of portfolio
-
State Street Corp Boston, MA5.09MShares$49.8 Million0.0% of portfolio
-
Baillie Gifford & CO2.38MShares$23.3 Million0.01% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.3B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...